… of confirmed symptomatic COVID‐19, severe and critical COVID‐19, and serious … efficacy
of COVID‐19 vaccines, and this review is updated regularly on the COVID‐NMA platform (covid…

… This study evaluated the safety and effectiveness of the COVID-19 vaccine through systematic
literature review and qualitative analysis for the published COVID-19 vaccine clinical trial …

… efficacy and safety of COVID-19 vaccines using published clinical trial data and real-world
data. We comprehensively analyzed the efficacy of the existing COVID-19 … that the efficacy of …

… coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval. Their safety
and efficacy … , with strong antibody responses and reassuring safety profiles but, with the …

… These new variants may threaten our current attempts at controlling Covid-19 and lead to …
evaluate the efficacy, immunogenicity, and safety of NVX-CoV2373 in preventing Covid-19 in …

… Here, we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 …
the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in preventing Covid-19 in …

… BNT162b2 had a favorable safety … Safety, efficacy, and immunogenicity data from participants
12 to 15 years of age in this trial have been reported. Here, we report safety and efficacy …

… ’ safety, efficacy, and immunogenicity against SARS-CoV-2. Here, we mainly focused on
available RCTs publications on the safety, efficacy, and immunogenicity of COVID-19 vaccines. …

… The results of clinical studies of the efficacy of Covid-19 … protein were shown to have an
efficacy of 90 to 96%. These … been widely used as the Covid-19 vaccine target (four vaccines …

… efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines. This study analyzed
the efficacy of COVID-19 … Published phase I, phase II, and phase III trials analyzing safety and …